Substitution of Cannabis for Prescribed Medications in the Management of Anxiety and Depression Among Midlife Women: A Cross‐Sectional Study
Open Access
- 28 June 2026
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 9 (7) , e72746
Abstract
Background and Aims: Given the rising prevalence of cannabis use as an alternative strategy for managing mental health symptoms, there is a crucial need to understand the determinants of substitution behavior, particularly among midlife women who may experience distinct psychosocial and clinical profiles. This study examined the predictors of cannabis substitution among midlife women by comparing profiles of women who substituted cannabis for antidepressant medications versus those who substituted for anxiolytic medications. Methods: A cross‐sectional survey of 172 women who reported substituting cannabis for either anxiety or depression medications was conducted. Measures included the PHQ‐8, OASIS, AUDIT, and ACEs. Logistic regression was used to identify predictors of substitution behavior. Results: Among participants, 88 (51%) substituted cannabis for antidepressants and 84 (49%) for anxiolytics. Clinically significant anxiety ( M = 12.5, SD = 4.3) and depression ( M = 11.6, SD = 5.3) were observed. Average ACE scores exceeded four in both groups. In multivariate models, sleep difficulties (OR = 4.2, 95% CI: 2.1–8.0) and alcohol use (OR = 1.1, 95% CI: 1.01–1.09) predicted substitution for anxiety. For depression, predictors included sleep difficulties (OR = 6.6, 95% CI: 3.1–14.1), alcohol use (OR = 1.1, 95% CI: 1.1–1.2), lower education (OR = 0.71, 95% CI: 0.53–0.95), and loneliness (OR = 2.0, 95% CI: 1.2–3.8). Conclusion: Sleep difficulties and alcohol use were found to be strong predictors for substituting cannabis for anxiety and depression medications among middle‐aged women. These findings highlight the need for clinical awareness of symptom‐specific substitution patterns and emphasize the importance of addressing co‐occurring sleep and substance use problems.Keywords
This publication has 38 references indexed in Scilit:
- Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patientsInternational Journal of Drug Policy, 2017
- Depression in midlife womenMaturitas, 2016
- Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different?Psychological Medicine, 2014
- Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for useInternational Journal of Drug Policy, 2013
- Health Effects of Using Cannabis for Therapeutic Purposes: A Gender Analysis of Users’ PerspectivesSubstance Use & Misuse, 2010
- The PHQ-8 as a measure of current depression in the general populationJournal of Affective Disorders, 2009
- Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS)Depression and Anxiety, 2006
- Chronic fatigue and anxiety/depression: A twin studyThe British Journal of Psychiatry, 2002
- Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in AdultsAmerican Journal of Preventive Medicine, 1998
- Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐IIAddiction, 1993